Eurekam Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $6.34M

  • Investors
  • 7

Eurekam General Information

Description

Developer of artificial intelligence-based image technologies designed to offer the process of controlled drug protection. The company's technologies help to reach verified and archived preparations, avoid posterior sampling errors and double visual inspection, reduce medication errors and protect from legal risks, enabling the healthcare sector to get a response that matches the regulatory requirements.

Contact Information

Website
www.eurekam.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4 Rue Louis Tardy
  • 17140 Lagord
  • France
+33 05
Primary Industry
Outcome Management (Healthcare)
Other Industries
Drug Discovery
Corporate Office
  • 4 Rue Louis Tardy
  • 17140 Lagord
  • France
+33 05

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eurekam Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 05-Oct-2022 $6.34M Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Later Stage VC 04-Apr-2018 $1.85M $2.5M Completed Generating Revenue
1. Early Stage VC 23-Jul-2013 $652K $652K Completed Generating Revenue
To view Eurekam’s complete valuation and funding history, request access »

Eurekam Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
ADP A
To view Eurekam’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Eurekam Patents

Eurekam Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3797511-A1 Device and method for recognising a label deposited on an object in order to securely produce drug preparations Active 22-May-2018
EP-3797511-B1 Device and method for recognising a label deposited on an object in order to securely produce drug preparations Active 22-May-2018
WO-2019224438-A1 Device and method for recognising a label deposited on an object in order to securely produce drug preparations Inactive 22-May-2018
FR-3081584-A1 Device and method for recognizing a label deposited on an object for secure preparation of medicinal products Active 22-May-2018
FR-3081584-B1 Device and method for recognizing a label deposited on an object for the secure preparation of drug preparations Active 22-May-2018 B25J21/02
To view Eurekam’s complete patent history, request access »

Eurekam Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eurekam Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Impact Partners (Paris) Impact Investing Minority
Aquiti PE/Buyout Minority
Région Nouvelle-Aquitaine Government Minority
Sofimac Innovation Venture Capital Minority
Bpifrance Sovereign Wealth Fund Minority
You’re viewing 5 of 7 investors. Get the full list »

Eurekam FAQs

  • When was Eurekam founded?

    Eurekam was founded in 2012.

  • Where is Eurekam headquartered?

    Eurekam is headquartered in Lagord, France.

  • What is the size of Eurekam?

    Eurekam has 27 total employees.

  • What industry is Eurekam in?

    Eurekam’s primary industry is Outcome Management (Healthcare).

  • Is Eurekam a private or public company?

    Eurekam is a Private company.

  • What is Eurekam’s current revenue?

    The current revenue for Eurekam is .

  • How much funding has Eurekam raised over time?

    Eurekam has raised $8.84M.

  • Who are Eurekam’s investors?

    Impact Partners (Paris), Aquiti, Région Nouvelle-Aquitaine, Sofimac Innovation, and Bpifrance are 5 of 7 investors who have invested in Eurekam.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process